SCHEMBL837827

SCHEMBL837827

N=C(Cc1c(Cl)cccc1Cl)NO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.50
KMT2A Q03164 3/20 0.44
ADRA2A P08913 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTR1A P08908 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
MAOA P21397 1/20 0.42
ADRA1D P25100 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
ADRA1A P35348 1/20 0.42
DRD3 P35462 1/20 0.42
OPRK1 P41145 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL838228 0.80 PNMT (0.50) KMT2AMEN1LMNACYP3A4CYP2D6
SCHEMBL641851 0.78 PKM (0.50) KMT2AMEN1LMNACYP3A4CYP2D6
SCHEMBL835822 0.76 P2RX7 (0.38) AKR1B1KMT2AMEN1LMNACYP3A4
SCHEMBL10391426 0.76 CYP1A2 (0.45) KMT2AADRA2AMEN1LMNACYP3A4
SCHEMBL14464764 0.76 AKR1B1 (0.56) AKR1B1KMT2AADRA2AMEN1LMNA
SCHEMBL837843 0.75 BACE1 (0.39) KMT2AMEN1MAPTSMN1; SMN2TAAR1
SCHEMBL13485815 0.75 KMT2A (0.62) AKR1B1KMT2AADRA2AMEN1LMNA
SCHEMBL1021475 0.74 AKR1B1 (0.54) AKR1B1KMT2AADRA2AMEN1LMNA
SCHEMBL5220871 0.73 AKR1B1 (0.48) AKR1B1KMT2AADRA2AMEN1LMNA
Hydrochloric Acid SCHEMBL1182809 0.72 ADRA2A (0.55) AKR1B1KMT2AADRA2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2272848-B1 Xanthine derivatives as selective HM74A agonists GLAXOSMITHKLINE LLC (US) 2012-12-26 EP disclosed
US-8143264-B2 Xanthine derivatives as selective HM74A agonists GLAXOSMITHKLINE LLC (US) 2012-03-27 US disclosed
US-20110257205-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GLAXOSMITHKLINE LLC 2011-10-20 US disclosed
EP-2272848-A1 Xanthine derivatives as selective HM74A agonists Glaxosmithkline LLC (US) 2011-01-12 EP disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GPR84, XDH, GPR88 AKR1B1 558/4885KMT2A 2469/4885ADRA2A 15/4885
US-20110257205-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GPR84, GPR88, XDH AKR1B1 832/4885KMT2A 2167/4885ADRA2A 16/4885
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 AKR1B1 583/4885KMT2A 2745/4885ADRA2A 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.